Ginger against cancer: what scientific studies really say

More than 5,000 PubMed studies examine the anti-cancer properties of ginger and turmeric. The in vitro and animal results are remarkable — but transposition to humans requires nuances that most “wellness” sites ignore. Here's what the science really says.

What the studies show (in vitro and animal)

The anti-cancer mechanisms of ginger

Inhibition of NF-κB : chronic activation of NF-κB is a hallmark of cancer (Aggarwal et al., 2004). Ginger and turmeric both inhibit this pathway. Induction of apoptosis : 6-shogaol activates caspases 3 and 9, triggering programmed cell death in cancer cells (Gan et al., 2013). Anti-angiogenesis : curcumin reduces VEGF, limiting tumor neovascularization.

The Warburg effect and sugar

Otto Warburg (Nobel Prize 1931) identified that cancer cells metabolize glucose 10-200x faster than normal cells — the “Warburg effect”. Although the sugar-cancer relationship is complex, chronic hyperinsulinemia is an established risk factor for colon, breast and pancreatic cancers (Giovannucci, Diabetes Care, 2010).

⚠️ Important limitations

Ginger and turmeric are NOT cancer treatments. The promising results are mainly in vitro — the concentrations used in the laboratory are often impossible to achieve through food. The research is in the early stages. Never replace oncological treatment with supplements.

FAQs

Can ginger cure cancer?
No. Ginger shows anticancer properties in vitro (apoptosis, NF-κB inhibition) but the evidence in humans remains preliminary. It is an interesting dietary supplement, not a treatment.

Is curcumin used in oncology?
Clinical trials are exploring curcumin as an adjuvant (in addition to chemotherapy). The results are encouraging but insufficient for firm clinical recommendations.

By Loïc De Vrye — founder of INTI, Me Time Scomm. Sources: PubMed.

INTI — organic ginger + turmeric + black pepper, 1.19 g of sugar/100 ml.